Table of Contents
Volume 4 | Issue 4
Publication Date: September 2007- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
178-179 |
Hitting Our Stride Jeffrey Crawford |
|
Comprehensive Reviews | ||
182-187 |
Urinary N-Telopeptide Is a Rapid Predictor of Response to and Palliative Benefit from Bisphosphonate Therapy in Patients with Metastatic Breast Cancer Christine Simmons, Reuben J. Broom, David E. C. Cole, George Dranitsaris, Mark Clemons |
|
188-197 |
The Effect of Palifermin on Chemotherapy- and Radiation Therapy—Induced Mucositis: A Review of the Current Literature Anne W. Beaven, Thomas C. Shea |
|
198-202 |
Sunshine and Rash: Testing the Role of Sunscreen to Prevent Epidermal Growth Factor Receptor Inhibitor—Induced Rash Aminah Jatoi |
|
Original Contributions | ||
203-210 |
Rapid and Sustained Influence of Intravenous Zoledronic Acid on Course of Pain and Analgesics Consumption in Patients with Cancer with Bone Metastases: A Multicenter Open-Label Study Over 1 Year Albrecht Kretzschmar, Thomas Wiegel, Salah-Eddin Al-Batran, Hans Fokke Hinrichs, Manfred Kindler, Thomas Steck, Hans Jochen Illiger, Volker Heinemann, Katja Schmidt, Ulrike Haus, Alexandra Kirner, Gerhard Ehninger |
|
211-218 |
Palmar-Plantar Erythrodysesthesia in Patients Receiving Capecitabine and Intratumor Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase: Is There a Pharmacologic Explanation? Muhammad Wasif Saif, Vinni Juneja, Glenda Black, Jennifer Thronton, Martin R. Johnson, Robert B. Diasio |
|
219-224 |
Phase II Evaluation of Desipramine for the Treatment of Hot Flashes Debra L. Barton, Charles L. Loprinzi, Pamela Atherton, Jane Raymond, Tait Shanafelt, Stephanie Hines, Fran Palmieri, Teresa Rummans, Alex A. Adjei, Jeff Sloan |
|
225-232 |
An Extended Dosing Regimen of Epoetin Alfa 60,000 Units Every 2 Weeks in Anemic Patients with Cancer Receiving Chemotherapy Stephanie A. Gregory, John Xie, Tomek Szczudlo, Denise Williams, Richard C. Woodman, Francois E. Wilhelm |
|
233-240 |
Symptom Burden for Patients with Metastatic Colorectal Cancer Treated with First-Line FOLFOX or FOLFIRI with and Without Bevacizumab in the Community Setting Barry V. Fortner, Lee S. Schwartzberg, Edward J. Stepanski, Arthur C. Houts |
|
241-246 |
Topiramate in the Treatment of Neuropathic Pain in Patients with Cancer Edmond A. Bendaly, Carol A. Jordan, Sandra S. Staehler, Daniel A. Rushing |
|
Current Trials | ||
247-250 |
A Phase II/III Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Ginger (Zingiber officinale) for Nausea Caused by Chemotherapy for Cancer: A Currently Accruing URCC CCOP Cancer Control Study Jane T. Hickok, Joseph A. Roscoe, Gary R. Morrow, Julie L. Ryan |
|
251-253 |
Vitamin E for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: Rationale for an Ongoing Clinical Trial Lisa Kottschade, Charles Loprinzi, Ravi Rao |
|